ABT-288 is under investigation in clinical trial NCT01018875 (Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease).
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Benzylpenicilloyl polylysine | ABT-288 may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent. |
| Betahistine | The therapeutic efficacy of Betahistine can be decreased when used in combination with ABT-288. |
| Hyaluronidase (ovine) | The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with ABT-288. |
| Hyaluronidase (human recombinant) | The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with ABT-288. |
| Hyaluronidase | The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with ABT-288. |
| Amphetamine | Amphetamine may decrease the sedative activities of ABT-288. |
| Phentermine | Phentermine may decrease the sedative activities of ABT-288. |
| Pseudoephedrine | Pseudoephedrine may decrease the sedative activities of ABT-288. |
| Benzphetamine | Benzphetamine may decrease the sedative activities of ABT-288. |
| Diethylpropion | Diethylpropion may decrease the sedative activities of ABT-288. |
| Lisdexamfetamine | Lisdexamfetamine may decrease the sedative activities of ABT-288. |
| Mephentermine | Mephentermine may decrease the sedative activities of ABT-288. |
| MMDA | MMDA may decrease the sedative activities of ABT-288. |
| Midomafetamine | Midomafetamine may decrease the sedative activities of ABT-288. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may decrease the sedative activities of ABT-288. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may decrease the sedative activities of ABT-288. |
| Tenamfetamine | Tenamfetamine may decrease the sedative activities of ABT-288. |
| Chlorphentermine | Chlorphentermine may decrease the sedative activities of ABT-288. |
| Methylenedioxyethamphetamine | Methylenedioxyethamphetamine may decrease the sedative activities of ABT-288. |
| Dextroamphetamine | Dextroamphetamine may decrease the sedative activities of ABT-288. |
| Metamfetamine | Metamfetamine may decrease the sedative activities of ABT-288. |
| Iofetamine I-123 | Iofetamine I-123 may decrease the sedative activities of ABT-288. |
| Ritobegron | Ritobegron may decrease the sedative activities of ABT-288. |
| Mephedrone | Mephedrone may decrease the sedative activities of ABT-288. |
| Methoxyphenamine | Methoxyphenamine may decrease the sedative activities of ABT-288. |
| Gepefrine | Gepefrine may decrease the sedative activities of ABT-288. |
| 2,5-Dimethoxy-4-ethylthioamphetamine | 2,5-Dimethoxy-4-ethylthioamphetamine may decrease the sedative activities of ABT-288. |
| Phendimetrazine | Phendimetrazine may decrease the sedative activities of ABT-288. |
| Hyoscyamine | ABT-288 may increase the anticholinergic activities of Hyoscyamine. |